vinflunine,docetaxel,erdafitinib,pembrolizumab
pierre fabre,merck,janssen
['thor trial', 'urothelial', 'congrat', 'thanks']
today, our patients with metastatic #urothelialcancer have another option for treatmt. molecularly selected pts by fgfr3/2 gene alt have the opportunity to receive a driven tki. congrats for this achievement at thor trial &amp; thanks to for such a brilliant talk #asco23 
Jefe del Servicio de #Oncología Médica y Director de Investigación Clínica de la Fundación MD Anderson Cancer Center Madrid. Opinions are my own